MEND
New York
About MEND
MEND is a health-science company that develops clinically backed nutrition products and remote wellness programs designed to support healing, recovery, and overall physiological resilience. Its product portfolio includes specialized nutritional formulas aimed at enhancing recovery from surgery, injury, joint replacement, and athletic strain, as well as daily wellness and performance support options formulated with research-informed ingredients. The company also offers a digital care platform called Upgraid, which provides remote coaching, monitoring, and personalized support intended to improve patient readiness for procedures and long-term health outcomes. Mend’s approach blends “food as medicine” principles with digital health tools to help patients and clinicians integrate nutrition and behavior-focused strategies into care pathways. Products and services are used in collaboration with healthcare providers in contexts like orthopedic recovery and surgical optimization to potentially enhance biomarkers and support more effective healing journeys.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $44.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2025)
- Website: mend.me
- Phone: 9174889897
Industries & Categories
Biotechnology, Health Care, Life Science, Nutraceutical
Social Profiles
Canonical: https://fsome.com/organization/mend-43451 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.